2-[(1,3-benzodioxol-5-yl]methyl]-5-ethyl-4-[4-(1H-imidazol-1-yl)phenoxy]pyrimidine | 1100925-15-2

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 唑类
• 英文名称: 2-[(1,3-benzodioxol-5-yl]methyl]-5-ethyl-4-[4-(1H-imidazol-1-yl)phenoxy]pyrimidine
• 英文别名: 2-(1,3-Benzodioxol-5-ylmethyl)-5-ethyl-4-(4-imidazol-1-ylphenoxy)pyrimidine
• CAS: 1100925-15-2
• 化学式: C₂₃H₂₀N₄O₃
• 分子量: 400.437
• InChiKey: NCDWYOIYLYDAPR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  30
• 可旋转键数：
  6
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.17
• 拓扑面积：
  71.3
• 氢给体数：
  0
• 氢受体数：
  6

文献信息

• N-heterocyclic derivatives as NOS inhibitors
  申请人：——

  公开号：US20020010190A1

  公开（公告）日：2002-01-24

  N-Heterocyclic derivatives selected from the group consisting of the following formulae: 1 where Z 1 , Z 2 , Z 3 , R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are described herein, are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.

  本文描述了从以下公式组成的群体中选择的N-杂环衍生物：1其中Z1，Z2，Z3，R1，R2，R3，R4，R5和R6如下所述，可用作一氧化氮合酶的抑制剂。本文还描述了包含这些化合物的制药组合物，使用这些化合物作为一氧化氮合酶抑制剂的方法以及合成这些化合物的过程。
• N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS
  申请人：SCHERING AKTIENGESELLSCHAFT

  公开号：EP1268471A1

  公开（公告）日：2003-01-02
• US6525051B2
  申请人：——

  公开号：US6525051B2

  公开（公告）日：2003-02-25
• [EN] N-HETEROCYCLIC DERIVATIVES AS NOS INHIBITORS<br/>[FR] DERIVES N-HETEROCYCLIQUES UTILISES EN TANT QU'INHIBITEURS DE L'ONS
  申请人：SCHERING AG

  公开号：WO2001072744A1

  公开（公告）日：2001-10-04

  N-Heterocyclic derivatives selected from the group consisting of the formulae (I), (II), (III) and (IV): where Z?1, Z2, Z3, R1, R2, R3, R4, R5 and R6¿ are described herein, are useful as inhibitors of nitric oxide synthase. Pharmaceutical compositions containing these compounds, methods of using these compounds as inhibitors of nitric oxide synthase and processes for synthesizing these compounds are also described herein.